Background Image
Table of Contents Table of Contents
Previous Page  149 / 658 Next Page
Information
Show Menu
Previous Page 149 / 658 Next Page
Page Background

Improved Quantitative Selectivity of Clenbuterol

in Human Urine Using High Resolution on the

TSQ Quantum Mass Spectrometer

Mark Churchill,

1

Mark Harrison,

1

John Henninge,

2

and Hanne Lund

2

1

Thermo Fisher Scientific, Stafford House, 1 Boundary Park, Boundary Way, Hemel Hempstead, HP2 7GE, UK;

2

Aker University Hospital, Hormone Laboratory, Section for Doping Analysis, Trondheimsveien, N-0514, Oslo, Norway

Key Words

• TSQ Quantum

• High Resolution

Analysis

• Improved

Sensitivity

• Quantitation

Application

Note: 310

The data presented here was acquired on a

TSQ Quantum mass spectrometer.

Introduction

Clenbuterol (Figure 1) is a beta-2-adrenergic agonist,

an effective bronchodilator drug used for the treatment

of human asthma. It relieves bronchial airway smooth

muscle contractions caused by Chronic Obstructive

Pulmonary Disease (COPD) and allergy-induced

respiratory distress.

Clenbuterol has significant anabolic effects and could

be used as a drug of abuse in athletes and livestock for

its muscle growth stimulant properties. It raises the body

temperature and hence facilitates fat tissue catabolism.

Due to Clenbuterol having these anabolic properties,

it must be routinely monitored in biological samples

by veterinary and human doping control laboratories.

Goal

One of the limitations to quantitation is the unequivocal

identification of analytes in biological samples due to

endogenous matrix interferents.

This report describes the use of high resolution on the

Thermo Scientific TSQ Quantum to exploit the negative

mass defect of a compound containing Chlorine, such as

Clenbuterol, and hence improve the selectivity of the

quantitative assay.

Clenbuterol (C

12

H

18

Cl

2

N

2

O, molecular weight 276.08

amu) was infused, 0.1 ng/µL, into the ESI source and the

four most abundant product ions for the MS/MS break-

down were determined using the automated compound

optimization procedure on the TSQ Quantum (Figure 2).

The transition yielding the most abundant product ion

(

m/z

203.0) was selected for the analysis of Clenbuterol.

Experimental Conditions

Sample Preparation:

Human urine extracts were prepared

using a C18 Solid Phase Extraction media. The extracted

urine was spiked with Clenbuterol in the concentration

range 0.1, 0.5, 1, 5, 10, 50 and 100 pg/µL for the calibra-

tion standards. No internal standard was used in this study.

Sample Analysis:

The spiked urine extracts were

chromatographed using a Thermo Scientific Surveyor

LC on a C18 100 mm

×

2.1 mm column at a flow rate of

H

2

N

Cl

NH

OH

Cl

Figure 1: Chemical structure of Clenbuterol

100

80

60

40

20

0

10

20

30

40

50

60

Breakdown Curve of Ion 277.1 m/z

Product Ions

Coll.Energy

203.0 m/z

22 v

259.0 m/z

16 v

132.0 m/z

36 v

168.0 m/z

36 v

Intensity: 1.64e+07

Pressure: 1.5 mTorr

Figure 2: Automated optimization of MS/MS parameters for Clenbuterol

DOWNLOAD